Significant advances have been made in the treatment of melanoma by targeting key cellular pathways, but additional targets are needed as many patients do not respond or relapse with resistant disease. MicroRNA-155 (MiR-155) has previously been shown to regulate melanoma cell growth and acts as a tumor suppressor. We tested a clinical population of melanoma tumors for miR-155 expression, and find that expression is low in most patients, although not predictive of outcome. We identified the protein kinase WEE1 as a novel target of miR-155. A mouse model of experimental metastasis finds that both increased expression of miR-155 and silencing of WEE1 lead to decreased metastases. Loss of miR-155 and increased expression of WEE1 may contribute to the metastatic phenotype in patients with melanoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522211 | PMC |
| http://dx.doi.org/10.1097/CMR.0000000000000545 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia.
Extracell Vesicles Circ Nucl Acids
July 2024
i3S - Institute for Research and Innovation in Health, University of Porto, Porto 4200, Portugal.
Cancer cachexia is a complex metabolic syndrome characterized by unintentional loss of skeletal muscle and body fat. This syndrome is frequently associated with different types of cancer and negatively affects the prognosis and outcome of these patients. It involves a dynamic interplay between tumor cells and adipose tissue, where tumor-derived extracellular vesicles (EVs) play a crucial role in mediating intercellular communication.
View Article and Find Full Text PDFExpression of microRNA-155 in thalassemic erythropoiesis.
PeerJ
September 2024
Faculty of Medical Technology, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Article Synopsis
- Ineffective erythropoiesis (IE) leads to anemia in beta-thalassemia, characterized by increased erythroblast proliferation without proper differentiation, resulting in immature red blood cells (RBCs).
- The study investigates the role of microRNA-155 (miR-155) in beta-thalassemia, focusing on its expression in erythroid cells from thalassemic bone marrow and its effects on cell differentiation and proliferation.
- Results show that miR-155 is upregulated during erythropoiesis in thalassemic mice, and manipulating its expression alters erythroid cell proliferation and differentiation, suggesting its potential significance in managing thalassemia-related anemia.
MicroRNAs as Epigenetic Regulators of Obesity.
Adv Exp Med Biol
September 2024
Faculty of Medicine, Department of General Surgery, Gazi University, Besevler, Ankara, Turkey.
In obesity, the process of adipogenesis largely determines the number of adipocytes in body fat depots. Adipogenesis is regulated by several adipocyte-selective micro-ribonucleic acids (miRNAs) and transcription factors that modulate adipocyte proliferation and differentiation. However, some miRNAs block the expression of master regulators of adipogenesis.
View Article and Find Full Text PDFThe role of miR-155-5p in inflammation and mechanical loading during intervertebral disc degeneration.
Cell Commun Signal
August 2024
Department of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, USA.
Background: Intervertebral disc (IVD) degeneration is a multifactorial pathological process resulting in the dysregulation of IVD cell activity. The catabolic shift observed in IVD cells during degeneration leads to increased inflammation, extracellular matrix (ECM) degradation, aberrant intracellular signaling and cell loss. Importantly, these pathological processes are known to be interconnected and to collectively contribute to the progression of the disease.
View Article and Find Full Text PDFCirculating adipose-tissue miRNAs in gastrointestinal cancer patients and their association with the level and type of adiposity at body composition analysis.
Front Mol Biosci
July 2024
Deparment of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Background: Adipose tissue (AT) wasting in cancer is an early catabolic event with negative impact on outcomes. Circulating miRNAs may promote body weight loss and cachexia. We measured circulating miRNAs linked to AT alterations and compared their levels between i) gastrointestinal (GI) cancer patients and controls, ii) cachectic and non-cachectic cancer patients, and iii) according to adiposity level and its distribution.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!